Lung surfactants/mucolytics:

Indications for: PULMOZYME

Management of cystic fibrosis in conjunction with standard therapies to improve pulmonary function.

Adults and Children:

<3months: not recommended. Use appropriate nebulizer. Do not dilute. >5yrs: 2.5mg once daily via nebulization; may increase to 2.5mg twice daily (see literature).

PULMOZYME Warnings/Precautions:

For patients <5yrs of age, use only if there is a potential for benefit in pulmonary function or in risk of respiratory tract infection. Use only with recommended nebulizers. Pregnancy (Cat.B). Nursing mothers.

PULMOZYME Interactions:

Do not mix with other drugs in nebulizer.

Adverse Reactions:

Pharyngitis, voice alteration, laryngitis, rash, chest pain, conjunctivitis.

How Supplied:

Amps (2.5mL)—30